Related Experiment Video
Updated: May 31, 2025
08:21
Forming Micro-and Nano-Plastics from Agricultural Plastic Films for Employment in Fundamental Research Studies
Published on: July 27, 2022
4.1K
The micro(nano)plastics perspective: exploring cancer development and therapy.
Xiangying Deng1,2,3, Yajun Gui1,2, Lin Zhao4,5
1Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
Molecular Cancer
|January 25, 2025
Summary
Microplastics, tiny plastic pollutants, may cause cancer through inflammation and oxidative stress. However, they also show promise as targeted drug carriers for cancer therapy.
Area of Science:
- Environmental Science
- Toxicology
- Oncology
Background:
- Microplastics (<5mm) are primary (industrial) or secondary (degradation) pollutants.
- They pose risks to ecosystems and human health.
- Potential mechanisms include cytotoxicity, inflammation, oxidative stress, and endocrine disruption.
Purpose of the Study:
- To review the carcinogenicity of microplastics.
- To explore their potential in cancer therapy.
- To identify future research directions.
Main Methods:
- Literature review of existing studies on microplastics and cancer.
- Analysis of microplastic properties and biological interactions.
- Evaluation of microplastics as drug delivery systems.
Main Results:
- Microplastics are linked to increased risk of lung, liver, and breast cancers.
- Mechanisms involve pro-inflammatory responses, oxidative stress, and endocrine disruption.
- Microplastics show potential as targeted drug carriers with high bioavailability.
Conclusions:
- Microplastics present a dual role: a potential carcinogen and a therapeutic tool.
- Further research is needed to understand long-term effects and specific mechanisms.
- Multidisciplinary collaboration is crucial for addressing microplastic-related health challenges.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:22MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
01:10Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K